ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.72
0.56%
US Tech 100
17,658.00
0.32%
S&P 500
5,214.08
0.51%
US Dollar vs CAD
1.36885
0.08%
Bitcoin
62,861.05
-0.30%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Transkaryotic Therapies (MM) (TKTX)

  7. Transkaryotic Therapies (MM) (TKTX) News

TKTX

Transkaryotic Therapies (TKTX)

Transkaryotic Therapies (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TKTX
DateTimeSourceHeadlineSymbolCompany
02/26/20203:05PMGlobeNewswire Inc.CRISPR Therapeutics Proposes Changes to the Board of DirectorsNASDAQ:TKTXTranskaryotic Therapies (MM)
07/27/200510:36AMPR Newswire (US)TKT Stockholders Approve Acquisition by ShireNASDAQ:TKTXTranskaryotic Therapies (MM)
07/14/20055:22PMPR Newswire (US)TKT Confirms That Board of Directors Unanimously Recommends That Stockholders Approve Shire TransactionNASDAQ:TKTXTranskaryotic Therapies (MM)
07/12/20058:01AMPR Newswire (US)TKT Issues Open Letter to StockholdersNASDAQ:TKTXTranskaryotic Therapies (MM)
06/27/20051:14PMPR Newswire (US)TKT to Hold Special Meeting of Stockholders on July 27, 2005NASDAQ:TKTXTranskaryotic Therapies (MM)
06/20/20058:01AMPR Newswire (US)TKT Reports Positive Top-Line Results of Hunter Syndrome Pivotal TrialNASDAQ:TKTXTranskaryotic Therapies (MM)
06/13/20058:41AMPR Newswire (US)TKT Announces Expiration of Both Hart-Scott-Rodino Waiting Period and SEC Review Period of Preliminary Proxy StatementNASDAQ:TKTXTranskaryotic Therapies (MM)
05/05/20058:00AMPR Newswire (US)TKT Announces First Quarter 2005 ResultsNASDAQ:TKTXTranskaryotic Therapies (MM)
04/27/20056:23PMPR Newswire (US)TKT Assessing Impact of Fire at Manufacturing FacilityNASDAQ:TKTXTranskaryotic Therapies (MM)
04/27/20054:30PMPR Newswire (US)TKT to Report First Quarter 2005 Financial Results on May 5, 2005NASDAQ:TKTXTranskaryotic Therapies (MM)
04/21/20059:50AMPR Newswire (US)TKT Announces Agreement to be Acquired by Shire for $1.6 BillionNASDAQ:TKTXTranskaryotic Therapies (MM)
04/20/20059:43AMPR Newswire (US)TKT Achieves GA-GCB Clinical MilestoneNASDAQ:TKTXTranskaryotic Therapies (MM)
03/29/20052:23PMPR Newswire (US)TKT Announces Appointment of Eric Pauwels as Senior Vice President, Global Commercial OperationsNASDAQ:TKTXTranskaryotic Therapies (MM)
03/28/20054:04PMPR Newswire (US)New Website Offers Comprehensive Information on Hunter SyndromeNASDAQ:TKTXTranskaryotic Therapies (MM)
03/24/20058:30AMPR Newswire (US)TKT to Present at Two Upcoming Healthcare ConferencesNASDAQ:TKTXTranskaryotic Therapies (MM)
03/17/20057:01AMPR Newswire (US)Notice to All Deutsche Bank Securities Inc. Clients From the Securities Arbitration Law Firm of Klayman & Toskes, P.A.NASDAQ:TKTXTranskaryotic Therapies (MM)
03/09/20051:21PMPR Newswire (US)TKT to Present at SG Cowen Securities' 25th Annual HealthCare ConferenceNASDAQ:TKTXTranskaryotic Therapies (MM)
02/23/20057:00AMPR Newswire (US)Strong Year of Execution Produces Solid 2004 Financial PerformanceNASDAQ:TKTXTranskaryotic Therapies (MM)
02/15/20058:31AMPR Newswire (US)Tamara L. Joseph Named General Counsel of TKTNASDAQ:TKTXTranskaryotic Therapies (MM)
02/10/20058:17AMPR Newswire (US)TKT to Report Fourth Quarter and Year-End 2004 Financial Results on February 23, 2005NASDAQ:TKTXTranskaryotic Therapies (MM)
02/04/20058:15AMPR Newswire (US)TKT Appoints Theresa Heggie as General Manager, EuropeNASDAQ:TKTXTranskaryotic Therapies (MM)
01/24/20052:59PMPR Newswire (US)Genzyme Sues to Halt TKT Gaucher TrialNASDAQ:TKTXTranskaryotic Therapies (MM)
01/11/20053:01PMPR Newswire (US)TKT Provides Update on Product Pipeline at JPMorgan Healthcare ConferenceNASDAQ:TKTXTranskaryotic Therapies (MM)
01/04/20059:02AMPR Newswire (US)TKT to Present at JPMorgan's Annual HealthCare ConferenceNASDAQ:TKTXTranskaryotic Therapies (MM)
12/09/200410:23AMPR Newswire (US)TKT to Present at Wachovia Biotechnology ConferenceNASDAQ:TKTXTranskaryotic Therapies (MM)
11/12/20048:15AMPR Newswire (US)TKT Announces Executive PromotionsNASDAQ:TKTXTranskaryotic Therapies (MM)
11/09/20047:35AMPR Newswire (US)TKT to Present At SG Cowen's Fifth Annual Global Health Care ConferenceNASDAQ:TKTXTranskaryotic Therapies (MM)
11/09/20047:30AMPR Newswire (US)TKT Reports Third Quarter 2004 Financial ResultsNASDAQ:TKTXTranskaryotic Therapies (MM)
10/29/20043:58PMPR Newswire (US)TKT To Report Third Quarter Financial Results On November 9, 2004NASDAQ:TKTXTranskaryotic Therapies (MM)
10/28/20045:01PMPR Newswire (US)TKT's Research Findings on Intrathecal Delivery of I2S Presented at ASHGNASDAQ:TKTXTranskaryotic Therapies (MM)
 Showing the most relevant articles for your search:NASDAQ:TKTX

Your Recent History

USOTC
EMGE
Emergent Health (PK)
USOTC
TXTM
ProText Mobility (PK)
USOTC
SONG
Music Licensing (PK)
USOTC
SHMP
NaturalShrimp (QB)
USOTC
RDAR
Raadr (PK)
USOTC
ECSL
Ecare Solutions (PK)
USOTC
BMXI
Brookmount Explorations (PK)
USOTC
RONN
Ronn Motor (PK)
USOTC
CLNV
Clean Vision (QB)
USOTC
YCRM
Yuenglings Ice Cream (PK)
USOTC
IPIX
Innovation Pharmaceuticals (CE)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
ELTP
Elite Pharmaceuticals (QB)
USOTC
GSTC
Globestar Therapeutics (PK)
USOTC
BABL
Buildablock (PK)
NASDAQ
NVDA
NVIDIA
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved